Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Upon limiting our sample to those without mental illness, two schizophrenia related genes (CNTNAP2, GABAR2) still had significant TOXO-associated variants at the p < .05 level, but did not pass the genome wide significance threshold after correction for multiple comparisons.
|
30610941 |
2019 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Disrupting CNTNAP2 rare variant burden was not higher in autism or schizophrenia compared to controls.
|
30586385 |
2018 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Particularly, GM reduction in thalamus, putamen and bilateral temporal gyrus in schizophrenia was associated with fALFF decrease in medial prefrontal cortex, both were also associated with genetic factors enriched in neuron development, synapse organization and axon pathways, highlighting genes including CSMD1, CNTNAP2, DCC, GABBR2 etc.
|
30341038 |
2018 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Contactin associated protein-like 2 (CNTNAP2) has emerged as a prominent susceptibility gene implicated in multiple complex neurodevelopmental disorders, including autism spectrum disorders (ASD), intellectual disability (ID), and schizophrenia (SCZ).
|
29610457 |
2018 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Common genomic variants of CNTNAP2 have been associated with autism, and a range of autistic phenotypes such as impaired language function, abnormal social behavior, intellectual deficiency, epilepsy, and schizophrenia have been associated with this gene.
|
26909962 |
2016 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous mutations in CNTNAP2 have been identified in patients with a range of complex phenotypes including intellectual disability, autism and schizophrenia.
|
26843181 |
2016 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
The CNTNAP2 gene is an excellent example of this, as it has recently been implicated in a broad range of phenotypes including autism spectrum disorder (ASD), schizophrenia, intellectual disability, dyslexia and language impairment.
|
23714751 |
2014 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
81 healthy controls and 44 patients with schizophrenia (all Caucasian) underwent DTI and genotyping of 31 SNPs within CNTNAP2.
|
23871450 |
2013 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
According to the location of significant signals, our study indicated that exon 13-15 of CNTNAP2 may play important roles in both schizophrenia and major depression in the Han Chinese population.
|
23123147 |
2013 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
At a gene level, CAM genes associated in all three samples (NRXN1 and CNTNAP2), which were previously implicated in specific language disorder, autism and schizophrenia.
|
20157312 |
2011 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
CTD_human |
At a gene level, CAM genes associated in all three samples (NRXN1 and CNTNAP2), which were previously implicated in specific language disorder, autism and schizophrenia.
|
20157312 |
2011 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
These data suggest that TCF4, NRXN1, and CNTNAP2 may participate in a biological pathway that is altered in patients with schizophrenia and other neuropsychiatric disorders.
|
20421335 |
2010 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The third interesting SNP rs802568 was at 7q35 within CNTNAP2 (p=8.92 × 10(-4), 1.38 × 10(-5), and 1.62 × 10(-7) for schizophrenia, bipolar disorder and meta-analysis, respectively).
|
20889312 |
2010 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Heterozygous copy-number variants and SNPs of CNTNAP2 and NRXN1, two distantly related members of the neurexin superfamily, have been repeatedly associated with a wide spectrum of neuropsychiatric disorders, such as developmental language disorders, autism spectrum disorders, epilepsy, and schizophrenia.
|
19896112 |
2009 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
Our data thus confirm an association of CNTNAP2 to epilepsy outside the Old Order Amish population and suggest that dosage alteration of this gene may lead to a complex phenotype of schizophrenia, epilepsy and cognitive impairment.
|
17646849 |
2008 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our data thus confirm an association of CNTNAP2 to epilepsy outside the Old Order Amish population and suggest that dosage alteration of this gene may lead to a complex phenotype of schizophrenia, epilepsy and cognitive impairment.
|
17646849 |
2008 |